According to
the new market research report "Surgical Sealants Market by Product (Natural
& Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Albumin, Human
blood), Indication (Hemostasis, Tissue Sealing), Application (CNS,
Cardiovascular, Cosmetic Surgery) - Global Forecast to 2021", analyzes and
studies the major market drivers, restraints, and opportunities in North
America, Europe, Asia-Pacific, and the Rest of the World.
The Surgical Sealants Market witnessed a healthy growth rate during the
last decade and is expected to grow at a CAGR of 9.6% between 2016 and 2021 to
reach 2.96 Billion by 2021.
The growth in this market is majorly
attributed to factors such as increasing need to manage blood loss in patients,
growing rate of surgeries being performed annually, greater uptake of
technologically advanced products, and increasing FDA and CE Mark approvals.
Moreover, factors like rising geriatric population, increasing prevalence and
incidence of chronic disorders, and increasing trauma and accident cases are
driving the adoption of these sealants and adhesives.
Browse and in-depth TOC on " Surgical Sealants Market "
212 - Tables
41 - Figures
265 - Pages
View more detailed
TOC @
https://www.marketsandmarkets.com/Market-Reports/surgical-sealants-adhesives-market-38230314.html
The Surgical
Sealants Market is segmented on the
basis of product, indication, application, and region. On the basis of product,
the market is segmented into natural/biological sealants and adhesives and
synthetic & semi-synthetic sealants and adhesives. The natural/biological
sealants and adhesives segment is further divided on the basis of type and
origin.
On the
basis of type, natural/biological sealants have been segmented into
polypeptide/protein-based and polysaccharide-based sealants and adhesives. The
polypeptide/protein-based sealants segment consists of fibrin, gelatin,
collagen, and albumin-based adhesives, while the polysaccharide-based sealants
segment comprises of chitosan-based and other polysaccharide-based adhesives.
On the basis of origin, the natural/biological
sealants and adhesives segment have been categorized into human blood and
animal-based adhesives. The synthetic and semi-synthetic sealants and adhesives
have been segmented into cyanoacrylates, polyethylene glycol hydrogels,
urethane-based adhesives, and other synthetic adhesives.
On the basis of indication, the Surgical Sealants Market has been segmented into surgical hemostasis,
tissue sealing, and tissue engineering. Based on application, the market is
segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological,
pulmonary, ophthalmic surgeries, and other applications.
In 2016, North America is expected to account for the largest
share of the market. The largest share of this regional segment is driven by
rising healthcare expenditure, the presence of many large and well-equipped
hospitals, greater uptake of technologically advanced medical products,
increasing FDA approvals for surgical sealants, and the presence of major
market players in this region.
However, the market in the Asia-Pacific region
is expected to grow at the highest CAGR, owing to growing per capita income,
increasing medical tourism, the presence of less stringent regulations, and
growing demand for quality healthcare. In addition, increasing investments by
major players in this region is propelling the market further.
Baxter International, Inc. (U.S.),
Johnson & Johnson (Ethicon, Inc.; U.S.), CryoLife, Inc. (U.S.), and C.R.
Bard, Inc. (U.S.) held the major share of the Surgical Sealants Market and will continue to dominate the market
between 2016 and 2021.
Some of the major players operating in
this market are Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen
AG (Germany), Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.),
Vivostat A/S (Denmark), and Sealantis Ltd. (Israel).
About MarketsandMarkets™
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’
revenues. Currently servicing 7500 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "Knowledge
Store" connects over 200,000 markets and entire value chains for deeper
understanding of the unmet insights along with market sizing and forecasts of
niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™
INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email:
sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/surgical-sealants-adhesives-market.asp